# A Study of MFA-370 in Patients with Metastatic Urothelial Cancer

> **NCT05390645** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Ectin Research AB**

## Conditions studied

- Metastatic Urothelial Cancer

## Interventions

- **DRUG:** MFA-370

## Key facts

- **NCT ID:** NCT05390645
- **Lead sponsor:** Ectin Research AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor company was liquidated.
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05390645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05390645, "A Study of MFA-370 in Patients with Metastatic Urothelial Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05390645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*